Longitude Prize launches programme on accelerating innovation in diagnostic tests, essential to…
The programme consists of series of free, deep-dive, technical workshops with industry experts, plus package of bespoke 1-to-1…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Lab Diagnostics
Genomics + InVitro diagnostics
WHO advises 140 tests per day, per million population
The expansion of laboratory capacity has seen an exponential increase from one lab in Jan 2020 to 121 labs in March 2020 and to…
Thyrocare crosses 1 lakh PCR tests mark for COVID-19 testing
The company has scaled up the testing over the months and are now testing about 2500-3000 people a day
Thyrocare has crossed…
The significance of nutrigenomics and pharmacogenomics in times of COVID
The success of the Human Genome Project and the development of genomics tools have catalysed a new era in medicine and nutrition.…
Adamas University and Elmax Systems develops an AI-based COVID 19 diagnostic tool
The novelty is in a single point multi-hypothesis based faster detection of COVID-19 from Radiography images and other medical…
- Advertisement -
False Positive Results with BD SARS-CoV-2 Reagents for the BD Max System
The FDA is working with Becton Dickinson and Company (BD) to resolve this issue. The FDA will continue to keep clinical laboratory…
Mylab launches Compact XL – fully-automated Sample-to-PCR-ready system
Compact XL is cartridge-based machine, can test multiple samples concurrently. Compact XL can be used for wide range of RNA /…
FDA Issued Emergency Use Authorisation for COVID 19 Antigen Test
This is the second antigen test that the FDA has authorised for the detection of SARS-CoV-2 antigens
Our COVID-19 RT- PCR test kits are approved for use in over 50 countries
Given the unprecedented nature of the COVID 19 pandemic, Thermo Fisher Scientific’ has scaled up production of their RT-PCR assay…
Oncomine Precision Assay receives breakthrough device designation by FDA
The assay can be used to identify low-grade glioma patients with isocitrate dehydrogenase IDH1, IDH2 mutation